Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyper Eosinophilic Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02555371
What this trial is testing

Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients

Who this might be right for
Asthma
GlaxoSmithKline 306
Not applicableUnknownNCT04897113
What this trial is testing

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

Who this might be right for
HypercholesterolemiaHyperbilirubinemiaHyper IgE Syndrome+9 more
National Medical Research Center for Rehabilitation and Balneology 80
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Testing effectiveness (Phase 2)Study completedNCT05985694
What this trial is testing

AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Advagene Biopharma Co. Ltd. 40
Post-approval studies (Phase 4)Study completedNCT01171365
What this trial is testing

Small Particle Steroids in Refractory Asthma

Who this might be right for
Asthma
University of Nottingham 30
Not applicableLooking for participantsNCT00091871
What this trial is testing

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Who this might be right for
EosinophiliaHypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableNot Yet RecruitingNCT07174713
What this trial is testing

REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)

Who this might be right for
Asthma; Eosinophilic
Western University, Canada 200
Not applicableStudy completedNCT00255957
What this trial is testing

Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics

Who this might be right for
Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms
Nizam's Institute of Medical Sciences University, India 20
Not applicableStudy completedNCT03453021
What this trial is testing

Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
University Hospital, Grenoble 27
Not applicableUnknownNCT04414137
What this trial is testing

Description of Eosinophilic Pneumonia in BJI/PJI Treated by Daptomycin

Who this might be right for
Dactinomycin Adverse ReactionBone and Joint Infection
Hospices Civils de Lyon 20
Not applicableStudy completedNCT05180357
What this trial is testing

RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.

Who this might be right for
Severe Eosinophilic AsthmaNasal Polyps
AstraZeneca 273
Post-approval studies (Phase 4)Study completedNCT00632554
What this trial is testing

The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

Who this might be right for
Eosinophilic PneumoniaChronic Disease
Hamamatsu University 50
Large-scale testing (Phase 3)Ended earlyNCT01290887
What this trial is testing

Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 1,052
Not applicableStudy completedNCT03696914
What this trial is testing

Intense Airway Eosinophilia in Asthma

Who this might be right for
AsthmaEosinophilic Asthma
Laval University 918
Large-scale testing (Phase 3)Study completedNCT03306043
What this trial is testing

A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622

Who this might be right for
Hypereosinophilic Syndrome
GlaxoSmithKline 102
Not applicableUnknownNCT04612556
What this trial is testing

Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)

Who this might be right for
Asthma; EosinophilicSevere AsthmaLate-Onset Asthma
Aristotle University Of Thessaloniki 45
Large-scale testing (Phase 3)Ended earlyNCT05813288
What this trial is testing

Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

Who this might be right for
Eosinophilic AsthmaAsthma; EosinophilicAsthma
Areteia Therapeutics 654
Testing effectiveness (Phase 2)UnknownNCT00276926
What this trial is testing

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Who this might be right for
Hypereosinophilic SyndromeChronic Eosinophilic Leukemia (CEL)Myeloproliferative Disorders
University of Bologna
Post-approval studies (Phase 4)UnknownNCT06288516
What this trial is testing

BenRalizumab Effect on Airway Remodeling in Severe asTHma

Who this might be right for
Asthma; EosinophilicAirway Remodeling
Aristotle University Of Thessaloniki 45
Large-scale testing (Phase 3)Looking for participantsNCT07671001
What this trial is testing

Depemokimab in Participants of 6 to 11 Years of Age

Who this might be right for
Asthma
GlaxoSmithKline 34
Next Page